Emergent BioSolutions | درآمد خالص





درآمد خالص تغییر دادن تاریخ
Acadia Pharmaceuticals USD 71.78M 45.11M 2025-09
Akebia Therapeutics USD 6.11M 28.92M 2025-03
ALKERMES USD 82.76M 4.34M 2025-09
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amarin USD -7.74M 6.4M 2025-09
ANI Pharmaceuticals USD 26.27M 18.13M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Coherus Biosciences USD -56.57M 5.87M 2025-03
Emergent BioSolutions USD -261.3M 78.3M 2023-06
Exact Sciences USD -19.59M 18.41M 2025-09
Exelixis USD 193.58M 8.73M 2025-09
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Heron Therapeutics USD -4.85M 4.39M 2024-09
Ionis Pharmaceuticals USD -128.61M 252.16M 2025-09
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Lexicon Pharmaceuticals USD -53.43M 5.03M 2024-06
Lonza CHF 307M 22M 2024-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Myriad Genetics USD -27.4M 303.1M 2025-09
Nektar Therapeutics USD -37.06M 15.31M 2024-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Pacira USD 5.43M 10.28M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
United Therapeutics USD 338.7M 29.2M 2025-09
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12
Xoma USD -17.24M 33.23M 2024-09


Emergent BioSolutions درآمد خالص - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Feb 2026.